Astute Medical Inc, San Diego, recently shared results from a trial of the company’s NephroCheck test for early assessment of patient risk for acute kidney injury (AKI). The study resulted in improved patient outcomes, shorter hospital stays, and cost savings associated with a 66% reduction in moderate and severe acute…
Source: CLP
Read more: Astute Medical Test with Guided Intervention May Prevent Acute Kidney Injury